trending Market Intelligence /marketintelligence/en/news-insights/trending/fyfjq3unaf7yw6dybdfdqw2 content esgSubNav
In This List

Wize Pharma shareholders approve reverse stock split

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Wize Pharma shareholders approve reverse stock split

Israel's Wize Pharma Inc. said its shareholders approved a reverse stock split at a Feb. 19 special meeting.

Under the company's amended certificate of incorporation, the board can effect a reverse stock split by a ratio between 1-for-10 and 1-for-200 at any time before Feb. 19, 2019.